Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis

Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis Neurol Sci (2017) 38:1523–1524 DOI 10.1007/s10072-017-2958-x LETTER TO THE EDITOR Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis 1 2 1 1 1 S. Mariotto & F. Andreetta & A. Farinazzo & S. Monaco & S. Ferrari Received: 16 December 2016 /Accepted: 6 April 2017 /Published online: 6 May 2017 Springer-Verlag Italia 2017 Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis activity. Blood tests noted only a severe hyponatremia and the is characterized by psychiatric and neuropsychiatric manifes- presence of low titer anti-thyroid peroxidase and thyroglobu- tations preceded by prodromal symptoms in about 70% of lin antibodies. CSF analysis showed lymphocytic pleocytosis patients. It can occur as an autoimmune antibody-mediated (360 cells/μL with 98% lymphocytes); extensive viral PCR and cultures ruled out an infectious etiology. She was treated non-paraneoplastic syndrome or as a paraneoplastic disorder, triggered by different tumors, more often an ovarian teratoma. with acyclovir and intravenous corticosteroids with a progres- NMDARs are localized in neuronal post-synaptic membranes sive tapering. At the end of February, CSF analysis revealed and play a role in synaptic transmission and plasticity. In vitro the presence of anti-NMDAR antibodies that were absent in and in vivo investigations confirm that anti-NMDAR antibod- serum. The patient http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Neurological Sciences Springer Journals

Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis

Download PDF
2 pages

Loading next page...
1
 
/lp/springer_journal/persistence-of-anti-nmdar-antibodies-in-csf-after-recovery-from-udaNlrqxi0

References (5)

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer-Verlag Italia
Subject
Medicine & Public Health; Neurology; Neuroradiology; Neurosurgery; Psychiatry
ISSN
1590-1874
eISSN
1590-3478
DOI
10.1007/s10072-017-2958-x
Publisher site
See Article on Publisher Site

Abstract

Neurol Sci (2017) 38:1523–1524 DOI 10.1007/s10072-017-2958-x LETTER TO THE EDITOR Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis 1 2 1 1 1 S. Mariotto & F. Andreetta & A. Farinazzo & S. Monaco & S. Ferrari Received: 16 December 2016 /Accepted: 6 April 2017 /Published online: 6 May 2017 Springer-Verlag Italia 2017 Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis activity. Blood tests noted only a severe hyponatremia and the is characterized by psychiatric and neuropsychiatric manifes- presence of low titer anti-thyroid peroxidase and thyroglobu- tations preceded by prodromal symptoms in about 70% of lin antibodies. CSF analysis showed lymphocytic pleocytosis patients. It can occur as an autoimmune antibody-mediated (360 cells/μL with 98% lymphocytes); extensive viral PCR and cultures ruled out an infectious etiology. She was treated non-paraneoplastic syndrome or as a paraneoplastic disorder, triggered by different tumors, more often an ovarian teratoma. with acyclovir and intravenous corticosteroids with a progres- NMDARs are localized in neuronal post-synaptic membranes sive tapering. At the end of February, CSF analysis revealed and play a role in synaptic transmission and plasticity. In vitro the presence of anti-NMDAR antibodies that were absent in and in vivo investigations confirm that anti-NMDAR antibod- serum. The patient

Journal

Neurological Sciences – Springer Journals

Published: May 6, 2017

There are no references for this article.